These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2247946)

  • 41. Pharmacokinetics of co-trimazine (sulphadiazine plus trimethoprim) in geriatric patients.
    Bergan T; Allgulander S; Fellner H
    Chemotherapy; 1986; 32(6):478-85. PubMed ID: 3802953
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum and skin concentrations after multiple-dose oral administration of trimethoprim-sulfadiazine in dogs.
    Pohlenz-Zertuche HO; Brown MP; Gronwall R; Kunkle GA; Merritt K
    Am J Vet Res; 1992 Jul; 53(7):1273-6. PubMed ID: 1497202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A combination of sulphadiazine, trimethoprim and metronidazole or tinidazole in kala-azar.
    Bano P; Shahab SM
    J Assoc Physicians India; 1994 Jul; 42(7):535-6. PubMed ID: 7868522
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The influence of age on the pharmacokinetics of aditoprim in pigs after intravenous and oral administration.
    Riond JL; Müller P; Wanner M
    Vet Res Commun; 1992; 16(5):355-64. PubMed ID: 1494860
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bioequivalency studies on tablet formulation of tetroxoprim and sulphadiazine.
    Alkaysi HN; Salem MA; Gharaibeh AM; Gharaibeh KI; Badwan AA
    J Clin Pharm Ther; 1992 Apr; 17(2):97-9. PubMed ID: 1583085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Streptococcal meningitis in pigs: field trial to study the prophylactic effect of trimethoprim/sulphadiazine medication in feed.
    Guise HJ; Penny RH; Petherick DJ
    Vet Rec; 1986 Oct; 119(16):395-400. PubMed ID: 3798680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Studies on the dissolution and bioavailability of trimethoprim-sulfadiazine-sulfamethoxazole tablets].
    Shao J; Mao FF; Tu XD
    Yao Xue Xue Bao; 1992; 27(5):375-80. PubMed ID: 1442059
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Concentrations of sulphadiazine and trimethoprim in nasal secretion after co-trimazine administration.
    Ullmann U; Giebel W; Bamberg P
    J Antimicrob Chemother; 1983 Jan; 11(1):89-92. PubMed ID: 6826489
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum and synovial fluid steady-state concentrations of trimethoprim and sulfadiazine in horses with experimentally induced infectious arthritis.
    Bertone AL; Jones RL; McIlwraith CW
    Am J Vet Res; 1988 Oct; 49(10):1681-7. PubMed ID: 3189982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical pharmacokinetics of co-trimazine.
    Bergan T; Ortengren B; Westerlund D
    Clin Pharmacokinet; 1986; 11(5):372-86. PubMed ID: 3536256
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single daily doses of trimethoprim/sulphadiazine for three or 10 days in urinary tract infections.
    Gaudreault P; Beland M; Girodias JB; Thivierge RL
    Acta Paediatr; 1992 Sep; 81(9):695-7. PubMed ID: 1421911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanism of sulphadiazine enhancement of trimethoprim activity against sulphadiazine-resistant Enterococcus faecalis.
    Richards RM; Xing JZ; Gregory DW; Marshall D
    J Antimicrob Chemother; 1995 Oct; 36(4):607-18. PubMed ID: 8591935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concentrations of sulfadoxine and trimethoprim in plasma, lymph fluids and some tissues 24 h after intramuscular administration to Angora goats.
    Traş B; Elmas M; Yazar E; Baş AL; Keskin E; Daşci Z
    Vet Q; 1998 Apr; 20(2):62-4. PubMed ID: 9563162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of experimental Bordetella bronchiseptica infection in young pigs with potentiated sulphonamide in the drinking water.
    Giles CJ; Smith IM; Baskerville AJ; Oliphant J
    Vet Rec; 1981 Feb; 108(7):136-9. PubMed ID: 7269193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetic profile of sulphamonomethoxine-trimethoprim in horses after intravenous, intramuscular and oral administration.
    Carli S; Sonzogni O; Villa R; Bignazzi R; Montesissa C
    Res Vet Sci; 1993 Mar; 54(2):184-8. PubMed ID: 8460257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole during hemodialysis.
    Nissenson AR; Wilson C; Holazo A
    Am J Nephrol; 1987; 7(4):270-4. PubMed ID: 3500644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical efficacy of prophylactic administration of trimethoprim/sulfadiazine in a Streptococcus equi subsp. zooepidemicus infection model in ponies.
    Ensink JM; Bosch G; van Duijkeren E
    J Vet Pharmacol Ther; 2005 Feb; 28(1):45-9. PubMed ID: 15720514
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of a calf salmonellosis model to evaluate the therapeutic properties of trimethoprim and sulphadiazine and their mutual potentiation in vivo.
    White G; Piercy DW; Gibbs HA
    Res Vet Sci; 1981 Jul; 31(1):27-31. PubMed ID: 7313315
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacokinetics of sulphadoxine and trimethoprim and tissue irritation caused by two sulphadoxine-trimethoprim containing products after subcutaneous administration in pre-ruminant calves.
    Kaartinen L; Gips M; Laurila T; Härtel H; Soback S; Pyörälä S
    Vet Res; 2000; 31(5):517-26. PubMed ID: 11050747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Simultaneous determination of sulphadiazine and trimethoprim in plasma and tissues of cultured fish for residual and pharmacokinetic studies.
    Hormazabal V; Rogstad A
    J Chromatogr; 1992 Dec; 583(2):201-7. PubMed ID: 1478984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.